How has been the historical performance of 20 Microns?

Answer:The historical performance of 20 Microns shows a consistent growth trend in net sales and profit over the years, with net sales increasing from 701.69 Cr in Mar'23 to 912.83 Cr in Mar'25. The total operating income followed a similar trajectory, rising from 701.69 Cr in Mar'23 to 912.83 Cr in Mar'25. The operating profit (PBDIT) also demonstrated growth, moving from 88.66 Cr in Mar'23 to 121.15 Cr in Mar'25, although the operating profit margin slightly decreased from 12.22% to 12.81%. Profit before tax increased from 57.10 Cr in Mar'23 to 82.70 Cr in Mar'25, while profit after tax rose from 41.87 Cr to 62.48 Cr in the same period. The earnings per share (EPS) improved significantly from 11.85 in Mar'23 to 17.68 in Mar'25.

On the balance sheet side, total assets grew from 522.53 Cr in Mar'23 to 713.25 Cr in Mar'25, with total liabilities also increasing from 522.53 Cr to 713.25 Cr. Shareholder's funds rose from 293.58 Cr to 429.36 Cr, reflecting a solid increase in reserves from 275.96 Cr to 411.72 Cr. Cash flow from operating activities showed a decline from 63.00 Cr in Mar'23 to 31.00 Cr in Mar'25, while cash flow from investing activities worsened, moving from -17.00 Cr to -63.00 Cr. The net cash outflow in Mar'25 was -17.00 Cr, down from a positive inflow of 28.00 Cr in Mar'24.

Breakdown:
20 Microns has shown a robust growth pattern in its financial performance over the years. Net sales surged from 701.69 Cr in Mar'23 to 912.83 Cr in Mar'25, indicating a strong demand for its products. The total operating income mirrored this growth, reaching 912.83 Cr in Mar'25. Operating profit also increased significantly, from 88.66 Cr to 121.15 Cr, although the operating profit margin saw a slight decline. Profit before tax and profit after tax both demonstrated substantial increases, with profit after tax rising to 62.48 Cr in Mar'25. The company's earnings per share improved markedly, reflecting its enhanced profitability. On the balance sheet, total assets and liabilities rose in tandem, with shareholder's funds and reserves both showing healthy growth. However, cash flow from operating activities decreased, and cash flow from investing activities worsened, leading to a net cash outflow in Mar'25. Overall, 20 Microns has maintained a positive growth trajectory in sales and profits, despite some challenges in cash flow management.